Review



ffpe tissue—pyrosequencing  (Pyrosequencing Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Pyrosequencing Inc ffpe tissue—pyrosequencing
    Clinicopathological presentations of LCH patients
    Ffpe Tissue—Pyrosequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ffpe tissue—pyrosequencing/product/Pyrosequencing Inc
    Average 90 stars, based on 1 article reviews
    ffpe tissue—pyrosequencing - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Frequency detection of BRAF V600E mutation in a cohort of pediatric langerhans cell histiocytosis patients by next-generation sequencing"

    Article Title: Frequency detection of BRAF V600E mutation in a cohort of pediatric langerhans cell histiocytosis patients by next-generation sequencing

    Journal: Orphanet Journal of Rare Diseases

    doi: 10.1186/s13023-021-01912-3

    Clinicopathological presentations of LCH patients
    Figure Legend Snippet: Clinicopathological presentations of LCH patients

    Techniques Used: Mutagenesis

    Summary of published cohorts of LCH patients bearing BRAF V600E mutations in tissue
    Figure Legend Snippet: Summary of published cohorts of LCH patients bearing BRAF V600E mutations in tissue

    Techniques Used: Mutagenesis, Sequencing, Biomarker Discovery, Activation Assay, Expressing



    Similar Products

    ffpe tissue—pyrosequencing  (Pyrosequencing Inc)
    90
    Pyrosequencing Inc ffpe tissue—pyrosequencing
    Clinicopathological presentations of LCH patients
    Ffpe Tissue—Pyrosequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ffpe tissue—pyrosequencing/product/Pyrosequencing Inc
    Average 90 stars, based on 1 article reviews
    ffpe tissue—pyrosequencing - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Clinicopathological presentations of LCH patients

    Journal: Orphanet Journal of Rare Diseases

    Article Title: Frequency detection of BRAF V600E mutation in a cohort of pediatric langerhans cell histiocytosis patients by next-generation sequencing

    doi: 10.1186/s13023-021-01912-3

    Figure Lengend Snippet: Clinicopathological presentations of LCH patients

    Article Snippet: Heritier [ ] , French , 173/315 (55%) , 173/315 (55%) , 3.2 years, 0–17.9 years , 167:148, 1.13 , FFPE tissue—Pyrosequencing or AS-qPCR or ddPCR or IHC , Age, gender, stage, involvement, follow-up years, 5-year relapse, death, permanent consequence, therapy , Median follow-up years, skin, risk organ, second-line therapy and/or rescue therapy requirement.

    Techniques: Mutagenesis

    Summary of published cohorts of LCH patients bearing BRAF V600E mutations in tissue

    Journal: Orphanet Journal of Rare Diseases

    Article Title: Frequency detection of BRAF V600E mutation in a cohort of pediatric langerhans cell histiocytosis patients by next-generation sequencing

    doi: 10.1186/s13023-021-01912-3

    Figure Lengend Snippet: Summary of published cohorts of LCH patients bearing BRAF V600E mutations in tissue

    Article Snippet: Heritier [ ] , French , 173/315 (55%) , 173/315 (55%) , 3.2 years, 0–17.9 years , 167:148, 1.13 , FFPE tissue—Pyrosequencing or AS-qPCR or ddPCR or IHC , Age, gender, stage, involvement, follow-up years, 5-year relapse, death, permanent consequence, therapy , Median follow-up years, skin, risk organ, second-line therapy and/or rescue therapy requirement.

    Techniques: Mutagenesis, Sequencing, Biomarker Discovery, Activation Assay, Expressing